2013
DOI: 10.1039/c2cs35421g
|View full text |Cite
|
Sign up to set email alerts
|

Carbosilane glycodendrimers

Abstract: Glycodendrimers fascinate both carbohydrate chemists and biologists because of their ability to recognize lectins and enhance carbohydrate-protein interactions. These characteristics make glycodendrimers a valuable tool in glycoscience and chemical biology. Many glycodendrimers have been described to date; this tutorial review focuses specifically on carbosilane glycodendrimers. We present methodologies for synthesizing parent carbosilane dendrimers and describe their use in biological assays. We also describe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
60
0

Year Published

2013
2013
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(60 citation statements)
references
References 52 publications
(87 reference statements)
0
60
0
Order By: Relevance
“…General procedure: The general procedure for the preparation of spacerarmed 5,6-oxomethylidenenojirimycin (1N-ONJ) and 5,6-oxomethylidenemannojirimycin (1N-OMJ) derivatives (17)(18)(19)(20) is as follows. A solution www.chemeurj.org of 5,6-oxomethylidenenojirimycin (15) or 5,6-oxomethylidenemannojirimycin (16; 1.72 mmol) and N-Boc-1,6-diaminohexane (578 mL, 2.58 mmol) or N-Boc-1,9-diaminononane (667 mg, 2.58 mmol) in MeOH (7.2 mL) was stirred, under Ar atmosphere, at 65 8C for 24-48 h. The solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography using the eluent indicated in each case.…”
Section: Synthesismentioning
confidence: 99%
See 1 more Smart Citation
“…General procedure: The general procedure for the preparation of spacerarmed 5,6-oxomethylidenenojirimycin (1N-ONJ) and 5,6-oxomethylidenemannojirimycin (1N-OMJ) derivatives (17)(18)(19)(20) is as follows. A solution www.chemeurj.org of 5,6-oxomethylidenenojirimycin (15) or 5,6-oxomethylidenemannojirimycin (16; 1.72 mmol) and N-Boc-1,6-diaminohexane (578 mL, 2.58 mmol) or N-Boc-1,9-diaminononane (667 mg, 2.58 mmol) in MeOH (7.2 mL) was stirred, under Ar atmosphere, at 65 8C for 24-48 h. The solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography using the eluent indicated in each case.…”
Section: Synthesismentioning
confidence: 99%
“…Thus, many synthetic polyconjugates with various copies of an identical individual sugar recognition motif onto molecular, dendritic, polymeric, selfassembled or nanometric scaffolds have been developed aimed at mimicking and matching the arrangement of complementary lectin receptors in their natural mode of affinity enhancement. [13][14][15][16][17][18][19][20][21] The design of glycosidase inhibitors has instead been focused on monovalent glycomimetics with a resemblance to the natural substrate or to the corresponding transition state. [22][23][24] In contrast to most lectins, glycosidases may appear to be unpromising targets for multivalent binding because the active site, which is normally unique, is generally buried at the interior of the protein and not very accessible, preventing quelation and cross-linking phenomena and making sliding and rebinding of multitopic ligands improbable.…”
Section: Introductionmentioning
confidence: 99%
“…Glycopolymers with various architectures can be self‐assembled to generate assemblies such as micelles or vesicles . Glycodendrimers have also been extensively explored . However, carbohydrates have only recently been incorporated into LD hybrids.…”
Section: Introductionmentioning
confidence: 99%
“…Enzyme-linked lectin assay (ELLA) with WGA has enabled the identification of tetra-, penta-, and hexavalent glycocluster exhibiting higher binding affinity than the monomeric GlcNAc control [15]. On the basis of structural data and recent progress made in the understanding of multivalent effects, a large variety of synthetic glycoclusters based on peptide dendrimers [16], carbosilanes [17], and nanostructures [18] have been developed as ligands for studying biologically relevant targets or providing compounds with anti-pathogenic and anti-tumoral properties.…”
Section: Biological Evaluation Of Multivalent-type N-acetyl-d-glucosamentioning
confidence: 99%